Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

SHE:300813 Revenue

Zhejiang Tailin BioEngineering Co.,Ltd had revenue of 89.54M CNY in the quarter ending September 30, 2026, with 32.92% growth. This brings the company's total for the last twelve months to 381.27M, up 19.25% year-over-year. In the year 2025, Zhejiang Tailin BioEngineering Co.,Ltd had annual revenue of 339.54M, down -2.71%. That makes Zhejiang Tailin BioEngineering Co.,Ltd the 26,978th largest company in the world by revenue and 4,712th in China.

• Revenue (ttm): 381.27M
• Revenue Growth: +19.25%
• P/S Ratio: 5.96
• Revenue / Employee: 482.62K
• Employees: 790
• Market Cap: 2.27B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 308.64M 90.9%
• Unallocated Other Industries 30.90M 9.1%

By Geography

Chart

• China 297.22M 87.5%
• Foreign 42.32M 12.5%

Fiscal year ended Dec 31, 2025 See the full SHE:300813 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	339.54M	-9.46M	-2.71%
Dec 31, 2024	349.00M	79.14M	29.33%
Dec 31, 2023	269.86M	-104.02M	-27.82%
Jan 1, 2023	373.88M	90.63M	32.00%
Jan 1, 2022	283.25M	83.01M	41.46%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error